AlzChem Group AG Stock
Price
Target price
€120.20
€120.20
-7.680%
-10.0
-7.680%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
AlzChem Group AG Stock
Heavy losses for AlzChem Group AG today as the stock fell by -€10.000 (-7.680%).
For the coming years our community has positive and negative things to say abot the AlzChem Group AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of AlzChem Group AG in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AlzChem Group AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AlzChem Group AG | -7.680% | -0.153% | 2.358% | 191.275% | 130.035% | 520.000% | 564.286% |
| adesso SE | 1.000% | 2.626% | -13.224% | -11.166% | 2.275% | -49.324% | 61.691% |
| CENIT AG | -0.890% | 2.055% | 7.711% | -31.756% | 23.310% | -45.321% | -5.096% |
| Allgeier SE | -1.950% | 13.260% | 3.015% | 9.043% | 37.584% | -43.370% | -40.580% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18
Looking at the financials of AlzChem, a company in the Software & IT Services industry, one can observe a positive trend in the company's growth. Net income and total assets have gradually increased over the past three years, which is generally a positive sign. However, a closer examination of various financial aspects is necessary for a comprehensive analysis.
*Pros: *
Growth in total assets: The total assets for AlzChem have experienced consistent growth over the last three years, from €354.3 million in 2020 to €422.8 million in 2022. This growth reflects an improvement in the company's overall financial health.
Comments
systinvest hat das Wertpapier AlzChem Group AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more
News
EQS-News: Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
EQS-News: Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
EQS-News: Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members
EQS-News: Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members
EQS-News: Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched
EQS-News: Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched